ストックスクリーナーアプリを入手
0.6108
1.80%
0.0108
Longeveron Inc (LGVN) 最新ニュース
Longeveron Inc (LGVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Longeveron Inc (LGVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Longeveron Inc (LGVN) Cash Flow - TradingKey
Longeveron Inc (LGVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LGVN|Longeveron Inc|Price:0.600|Chg%:-0.007 - TradingKey
Longeveron Inc (LGVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Longeveron Inc (LGVN) Institutional Confidence - TradingKey
TradingKey - TradingKey
Longeveron Inc (LGVN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors - BioSpace
Longeveron Inc. Elects Deborah D. Ascheim, M.D., to Board of Directors - Quiver Quantitative
LGVN Stock Slips After Hours As FDA Flags Concerns On Rare Heart Defect Trial Design - Stocktwits
Longeveron elects Deborah Ascheim to board of directors - Bitget
Longeveron : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
Longeveron Enhances CEO Compensation and Retention Protections - TipRanks
Can Upcoming HLHS Trial Data Drive A Valuation Re-Rating For Longeveron? - RTTNews
Longeveron Inc. Signs Revised CEO Employment Agreement – Key Details from July 2026 Form 8-K Filing - Minichart
Longeveron Inc. (LGVN) director files Form 3 showing no share holdings - Stock Titan
Longeveron (NASDAQ: LGVN) updates CEO severance and equity vesting - Stock Titan
Longeveron Inc. (LGVN) director Leah Cann reports no stock ownership - Stock Titan
Longeveron Presents AAIC Data Showing Laromestrocel Stabilizes Brain Inflammation in Alzheimer’s Disease - Quiver Quantitative
Stem cell therapy laromestrocel links brain scan changes to better cognition in Alzheimer’s trial - Stock Titan
Longeveron (LGVN) Sees Modest Uptick as Stock Nears $0.69 ResistanceChandelier Stop - dars.gov.et
Longeveron Inc. Issues Special Equity Awards to Executive Chairman – SEC 8-K Filing Highlights Company Growth 7 - Minichart
Form 4 Longeveron LLC For: 8 July By Investing.com - Investing.com Nigeria
Longeveron (LGVN) CSO Hare granted 600k RSUs and 400k options - Stock Titan
Longeveron grants special equity awards to Executive Chairman - TipRanks
Longeveron (LGVN) awards 600,000 RSUs and 400,000 options to Executive Chairman - Stock Titan
Longeveron strengthens financial leadership with new CFO appointment - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
Longeveron names Marie Washburn as CFO - MSN
Form 4 Longeveron LLC For: 6 July By Investing.com - Investing.com Nigeria
Longeveron (NASDAQ: LGVN) CTO has 15,808 shares withheld for taxes - Stock Titan
Longeveron (LGVN) CFO has shares withheld to cover RSU tax obligations - Stock Titan
Longeveron (LGVN) CMO reports 22,505-share tax withholding after RSU vesting - Stock Titan
Longeveron Appoints Marie Washburn as Chief Financial Officer - citybiz
New Longeveron (NASDAQ: LGVN) CFO and reverse stock split approval - Stock Titan
Longeveron® Appoints Marie Washburn as Chief Financial Officer - GlobeNewswire
Longeveron Inc. (LGVN) Drops Over 7% as Biotech Sentiment WeighsEarly Entry Signals - dars.gov.et
Longeveron appoints Marie Washburn as CFO amid upcoming Phase 2b stem cell trial results. - Pluang
Longeveron (LGVN) Slips as Bearish Momentum Pressures Support at $0.66Mutual Fund Flow - dars.gov.et
LGVN Q1 2026 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Reports Wider-Than-Expected Loss - DonanımHaber
Price to sales forward of Longeveron Inc. – NASDAQ:LGVN - TradingView
Enterprise value to revenue forward of Longeveron Inc. – NASDAQ:LGVN - TradingView
Enterprise value to EBIT forward of Longeveron Inc. – NASDAQ:LGVN - TradingView
Enterprise value to EBITDA forward of Longeveron Inc. – NASDAQ:LGVN - TradingView
Price to book forward of Longeveron Inc. – NASDAQ:LGVN - TradingView
Price to earnings forward of Longeveron Inc. – NASDAQ:LGVN - TradingView
Longeveron® Announces Second Quarter 2025 Financial Results and Provides Business Update - The National Law Review
Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update - The National Law Review
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty Study - Stocktwits
Longeveron Inc. Class A Actuals & Estimates (NASDAQ:LGVN) - TradingView
LGVN Forecast — Price Target — Prediction for 2027 - TradingView
LGVN News | LONGEVERON INC-A (NASDAQ:LGVN) - ChartMill
Longeveron Inc (LGVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Longeveron Inc. (LGVN) Slides Near Support as Selling Pressure PersistsSentiment Shift - dars.gov.et
Longeveron’s Alzheimer’s trial data accepted for poster presentation - Investing.com UK
Longeveron’s Alzheimer’s trial data accepted for poster presentation By Investing.com - Investing.com South Africa
Longeveron to Present Additional Phase 2a Laromestrocel Data in Mild Alzheimer’s Disease at AAIC 2026 - Quiver Quantitative
Longeveron gets AAIC poster slot for Alzheimer’s stem cell data - Stock Titan
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):